全球營養補充和疫苗市場規模、佔有率、成長分析（按類型、最終用戶）- 產業預測，2024-2031 年

Global Nutraceutical & Vaccine Market Size, Share, Growth Analysis, By Type(Nutraceutical and Vaccine), By End-User(Adult and Children) - Industry Forecast 2024-2031

出版日期: 2024年03月18日 | 出版商:

SkyQuest | 英文 202 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球營養補充和疫苗市場規模估值為530.1億美元，從2023年的570.4億美元成長到2031年的1024.9億美元，並預計在預測期內成長（2024年預計複合年成長率為7.60 ） 2031 年至 2031 年的百分比。

近年來，在健康意識不斷提高的推動下，全球營養補充和疫苗市場經歷了顯著成長。營養補充食品機能性食品、營養補充和草藥產品組成，由於其潛在的健康益處和預防功效，在消費者對營養食品的認知不斷提高的推動下，越來越受到關注。同時，由於人們對疾病預防的興趣增加、疫苗開發的技術進步以及全球免疫舉措的擴大，疫苗產業的需求正在激增。世界各國政府致力於確保普遍獲得疫苗，世界衛生組織 (WHO) 全球疫苗行動計劃已得到 194 個成員國的核准。政府和非政府組織在加強這一部門方面發揮關鍵作用，透過定期評估來衡量疫苗接種目標的進展。聯合國兒童基金會和世界衛生組織宣布的綜合多年計畫等舉措旨在促進公平的疫苗取得並加強相關人員的參與。免疫覆蓋率的普及，例如白喉、百日咳和破傷風三聯疫苗目前廣泛應用於全球數百萬嬰幼兒，是市場強勁表現的關鍵驅動力，證實了這一趨勢。同時，富含必需營養素和抗氧化劑的營養補充因其預防性健康益處而得到越來越多的認可，世界各地的消費者都優先考慮他們的健康並改善醫療保健系統。我們相信可以節省成本並培養健康的人口。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

Pfizer Inc.（US）
Johnson & Johnson（US）
Novartis International AG（Switzerland）
Merck & Co., Inc.（US）
GlaxoSmithKline plc（UK）
Sanofi SA（France）
AstraZeneca plc（UK）
Abbott Laboratories（US）
Eli Lilly and Company（US）
Gilead Sciences, Inc.（US）
Amgen Inc.（US）
Bristol Myers Squibb（US）
Moderna, Inc.（US）
Roche Holding AG（Switzerland）
Novo Nordisk A/S（Denmark）
Takeda Pharmaceutical Company Limited（Japan）
Bayer AG（Germany）
Astellas Pharma Inc.（Japan）
Daiichi Sankyo Company, Limited（Japan）
AbbVie Inc.（US）

簡介目錄

Product Code: SQMIG20I2090

Global Nutraceutical & Vaccine Market size was valued at USD 53.01 billion in 2022 and is poised to grow from USD 57.04 billion in 2023 to USD 102.49 billion by 2031, growing at a CAGR of 7.60% during the forecast period (2024-2031).

The global nutraceutical and vaccine market has experienced remarkable growth recently, driven by increasing awareness of health and wellness benefits. Nutraceuticals, comprising functional foods, dietary supplements, and herbal products, are gaining traction due to their potential health advantages and preventive qualities, fueled by rising consumer consciousness regarding nutrition importance. Concurrently, the vaccine sector has seen a surge in demand, propelled by a heightened focus on disease prevention, technological advancements in vaccine development, and expanding global immunization initiatives. Governments worldwide are committed to ensuring universal access to vaccines, as evidenced by the World Health Organization's 'Global Vaccine Action Plan,' endorsed by 194 member states. With regular evaluations to gauge progress towards vaccination targets, governmental and non-governmental entities play vital roles in bolstering the sector. Initiatives like the comprehensive Multi-Year Plan, published by UNICEF and WHO, aim to promote equitable vaccine access and enhance stakeholder involvement. The growing immunization coverage, exemplified by the widespread administration of the Diphtheria, Pertussis, and Tetanus vaccine to millions of infants globally, underscores the market's flourishing trajectory. Meanwhile, nutraceuticals, enriched with essential nutrients and antioxidants, are increasingly recognized for their preventive health benefits, with consumers worldwide prioritizing their well-being, believing in the potential cost savings for healthcare systems and fostering healthier populations.

Top-down and bottom-up approaches were used to estimate and validate the size of the global nutraceutical & vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nutraceutical & Vaccine Market Segmental Analysis

Global Nutraceutical & Vaccine market is segmented by type, platform, and region. Based on type, the market can be segmented into nutraceutical, and vaccine. Based on platform, the market is segmented into adult and children. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Nutraceutical & Vaccine Market

A key catalyst propelling the global nutraceutical and vaccine market forward is the escalating focus on preventative healthcare. As awareness regarding the significance of preserving holistic wellness and warding off diseases continues to rise, there's an increasing need for products that provide health advantages and bolster the immune system. Consumers are proactively pursuing nutraceuticals and vaccines as integral components of their healthcare regimen. This surge is driven by evolving lifestyles, aging demographics, and the inclination to curtail healthcare expenditures by averting illnesses rather than addressing them post-manifestation.

Restraints in the Global Nutraceutical & Vaccine Market

One significant impediment facing the global nutraceutical and vaccine market lies in the strict regulatory frameworks and approval procedures. The journey from development to commercialization of nutraceuticals and vaccines demands meticulous testing, extensive clinical trials, and adherence to regulatory standards to guarantee safety, effectiveness, and quality. These procedures, albeit essential, often prove time-intensive and financially burdensome, particularly for smaller enterprises operating with constrained resources. The stringent regulatory environment may further lead to product launch delays and escalated compliance expenditures, consequently obstructing market expansion and stifling innovation within the nutraceutical and vaccine industries.

Market Trends of the Global Nutraceutical & Vaccine Market

A significant market trend in the global nutraceutical and vaccine industry is the rising interest in personalized and targeted healthcare solutions. Consumers are now more inclined towards products that meet their unique health requirements and genetic predispositions. This trend is driven by technological advancements like genomics, personalized medicine, and data analytics, enabling customized approaches to nutrition and vaccination. Market participants are adapting to this shift by creating personalized nutraceuticals and vaccines, delivering bespoke formulations and treatment strategies to tackle individual health issues and enhance outcomes. This trend underscores the move towards precision healthcare, acknowledging the diverse health needs of individuals.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Nutraceutical & Vaccine Market by Type

Market Overview
Nutraceutical and Vaccine

Global Nutraceutical & Vaccine Market by End-User

Market Overview
Adult and Children

Global Nutraceutical & Vaccine Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis International AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gilead Sciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol Myers Squibb (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Moderna, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Nordisk A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Astellas Pharma Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Daiichi Sankyo Company, Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments